The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of drugs approved for treating type 2 diabetes, has been explored in patients with NAFLD [10]
methionine, one of the key ingredients, may aggravate metabolic acidosis and a compromised liver may be unable to properly metabolize the compounds
This peptide is especially helpful for people dealing with long-term fatigue, inflammation, brain fog, or nerve issues
No validated human clinical dose exists for either peptide
Brighten: When we talk about midlife women and metabolic health, one of the most common frustrations that I hear as a clinician is I'm doing what's always worked for me, but my body isn't responding anymore, there's a good reason for that